期刊文献+

经肝动脉化疗栓塞术联合射频消融治疗巨大肝细胞癌1例报告 被引量:1

A case of large hepatocellular carcinoma treated by transcatheter arterial chemoembolization combined with radiofrequency ablation
下载PDF
导出
摘要 原发性肝癌是我国发病率第4位的恶性肿瘤,也是第3位肿瘤致死病因-([1])。肝细胞癌(以下简称肝癌)占原发性肝癌的85%-90%。在我国,肝炎病毒感染是导致肝癌的重要病因之一,以HBV为主-([2])。HBV相关肝癌的临床特征是患病早期肝功能代偿良好,无明显不适,但发现病变时肿瘤的直径多大于其他病毒导致的肝癌-([3]),因此在我国肝癌患者中,巨大肝癌(直径≥10 cm)常见。对于巨大肝癌,临床上常用的治疗手段有手术切除和多次经肝动脉化疗栓塞术(TACE),但治疗效果均不理想。
作者 刘博智 袁筑慧 李威 LIU Bozhi;YUAN Zhuhui;LI Wei(Oncology and Hepatobiliary Minimally Invasive Interventional Center,Beijing YouAn Hospital,Capital Medical University,Beijing 10005P,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2018年第7期1520-1522,共3页 Journal of Clinical Hepatology
关键词 肝细胞 化学栓塞 治疗性 导管消融术 病例报告 carcinoma hepatocellular chemoembolization therapeutic catheter ablation case reports
  • 相关文献

参考文献7

二级参考文献71

  • 1Meng-Su Zeng,Hui-Yi Ye,Liang Guo,Wei-Jun Peng,Jian-Ping Lu,Gao-Jun Teng,Josy Breuer,Yi Huan,Ping Li,Jian-Rong Xu,Chang-Hong Liang.Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients:a multicenter,open-label,phase Ⅲ study[J].Hepatobiliary & Pancreatic Diseases International,2013,12(6):607-616. 被引量:37
  • 2Yamada R, Kishi K, Sato M, Sonomura T, Nishida N, Tanaka K, Shioyama Y, Terada M, Kimura M. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg 1995; 19:795-800.
  • 3Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Ideo G. Transarterial oily chemo- embolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19:1115-1123.
  • 4Hatanaka Y, Yamashita Y, Takahashi M, Koga Y, Saito R, Nakashima K, Urata J, Miyao M. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995; 195:747-752.
  • 5Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Hirohashi S, Nishimura Y, Guo Q, Ohishi H, Nagano N, Yoshioka T. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellu- lar carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmaco1 1994; 33 Suppl: $60-$68.
  • 6Sakural M, Okamura J, Kuroda C. Transcatheter chemoembolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 1984; 54:387-392.
  • 7Yu YQ, Xu DB, Zhou xD, Lu JZ, Tang ZY, Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993; 71:62-65.
  • 8Nosaka T. The relationship between hepatoma and portal vein. Nippon Geka Gakkai Zasshi 1994; 95:807-813.
  • 9Choi SH, Chung JW, Lee HS. Hepatocellular carcinoma supplied by portal flow after repeated transcatheter arterial chemoembolization. A JR Am J Roentgeno12003; 181:889-890.
  • 10Lee KI-I, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS. Transcatheter arterial chemoembolization for hepatocellular carci- noma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics 2002; 22:1077-1091.

共引文献940

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部